Elevation of B-type natriuretic peptide is a sensitive marker of left ventricular diastolic dysfunction in patients with maintenance haemodialysis

Biomarkers

Volumn 15, Issue 6, 2010, Pages 533-537

  Liu, Hong ^a   Zhang, Ying Zi ^a   Gao, Min ^a   Liu, Bi Cheng ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

B type natriuretic peptide; Haemodialysis; Left ventricular diastolic dysfunction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE DIASTOLIC DYSFUNCTION; HEART LEFT VENTRICLE FAILURE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; TISSUE DOPPLER IMAGING;

ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RENAL DIALYSIS; ROC CURVE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 77955887643     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.493973     Document Type: Article

References (26)

1. Ahmed A, Rich MW, Sanders PW, Perry GJ, Bakris GL, Zile MR, Love TE, Aban IB, Shlipak MG. (2007). Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 99:393-398
2. Bertinchant JP. (2004). Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure. Arch Mal Coeur Vaiss 97:881-888
3. Bossola M, Tazza L, Vulpio C, Luciani G. (2008). Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible. Semin Dial 21:422-430
4. Collins AJ. (2003). Cardiovascular mortality in end-stage renal disease. Am J Med Sci 325:163-167
5. de Sa DD, Chen HH. (2008). The role of natriuretic peptides in heart failure. Curr Cardiol Rep 10:182-189
6. Devereux RB, Reichek N. (1977). Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618
7. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. (2000). Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 11:912-916
8. Haapio M, Ronco C. (2008). BNP and a renal patient: emphasis on the unique characteristics of B-type natriuretic peptide in end-stage kidney disease. Contrib Nephrol 161:68-75.
9. Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, Hoffmann W, Poller W, Schultheiss HP, Pauschinger M, Tschope C. (2007). Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 116:637-647
10. Khouri SJ, Maly GT, Suh DD, Walsh TE. (2004). A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 17:290-297
11. Kindermann M, Reil JC, Pieske B, van VDJ, Bohm M. (2008). Heart failure with normal left ventricular ejection fraction: what is the evidence? Trends Cardiovasc Med 18:280-292
12. Komaba H, Igaki N, Goto S, Yokota K, Takemoto T, Hirosue Y, Goto T. (2007). Adiponectin is associated with brain natriuretic peptide and left ventricular hypertrophy in hemodialysis patients with type 2 diabetes mellitus. Nephron Clin Pract 107:c103-8.
13. Lubien E, DeMaria A KP, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS. (2002). Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105:595-601.
14. Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Stancanelli B, Malatino LS. (2001). Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 59:1559-1566
15. Matayoshi T, Kato T, Nakahama H, Nakata H, Yoshihara F, Kamide K, Horio T, Nakamura S, Kawano Y. (2008). Brain natriuretic peptide in hemodialysis patients: predictive value for hemodynamic change during hemodialysis and cardiac function. Am J Nephrol 28:122-127
16. Meguid ENA, Bello AK. (2005). Chronic kidney disease: the global challenge. Lancet 365:331-340
17. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. (1997). Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527-1533
18. Nitta K, Kawashima A, Yumura W, Naruse M, Oba T, Kabaya T, Nihei H. (1998). Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am J Nephrol 18:411-415
19. Otterstad JE, Froeland G, St JSM, Holme I. (1997). Accuracy and reproducibility of biplane twodimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 18:507-513
20. Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. (2009). Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 191:341-366
21. Pozzoni P, Del VL, Pontoriero G, Di FS, Locatelli F. (2004). Long-term outcome in hemodialysis: morbidity and mortality. J Nephrol 17:s87-s95
22. Racek J, Kralova H, Trefil L, Rajdl D, Eiselt J. (2006). Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients. Nephron Clin Pract 103:c162-72.
23. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. (1989). Recommendations for quantitation of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of TwoDimensional Echocardiograms. J Am Soc Echocardiogr 2:358-367
24. Thomas JT, Kelly RF, Thomas SJ, Stamos TD, Albasha K, Parrillo JE, Calvin JE. (2002). Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med 112:437-445
25. Troughton RW, Richards AM. (2009). B-type natriuretic peptides and echocardiographic measures of cardiac structure and function. JACC Cardiovasc Imaging 2:216-225
26. Zeng C, Wei T, Jin L, Wang L. (2006). Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients. Intern Med J 36:552-557